Literature DB >> 30102776

Hepatitis C Virus Manipulates Humans as its Favorite Host for a Long-Term Relationship.

Ratna B Ray1,2, Ranjit Ray2.   

Abstract

Chronic hepatitis C virus (HCV) infection-associated liver disease is a global health problem. HCV often causes silent disease, and eventually progresses to end-stage liver disease. HCV infects hepatocytes; however, initial manifestation of liver disease is mostly displayed in hepatic stellate cells (HSCs), causing fibrosis/cirrhosis, and is believed to occur from inflammation in the liver. It remains unclear why HCV is not spontaneously cleared from infected liver in the majority of individuals and develops chronic infection with progressive liver disease. Direct-acting antivirals (DAAs) show excellent results in controlling viremia, although beneficial consequence in advanced liver disease remains to be understood. In this review, we highlight the current knowledge that has contributed to our understanding of the role of HCV in inflammation, immune evasion, metabolic disorders, liver pathogeneses, and efforts in vaccine development.
© 2018 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2019        PMID: 30102776      PMCID: PMC6351149          DOI: 10.1002/hep.30214

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  77 in total

1.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.

Authors:  Takaji Wakita; Thomas Pietschmann; Takanobu Kato; Tomoko Date; Michiko Miyamoto; Zijiang Zhao; Krishna Murthy; Anja Habermann; Hans-Georg Kräusslich; Masashi Mizokami; Ralf Bartenschlager; T Jake Liang
Journal:  Nat Med       Date:  2005-06-12       Impact factor: 53.440

2.  Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein.

Authors:  Michiari Okuda; Kui Li; Michael R Beard; Lori A Showalter; Frank Scholle; Stanley M Lemon; Steven A Weinman
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

3.  Generation of infectious hepatitis C virus in immortalized human hepatocytes.

Authors:  Tatsuo Kanda; Arnab Basu; Robert Steele; Takaji Wakita; Jan S Ryerse; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C.

Authors:  Frederik Nevens; Tania Roskams; Hans Van Vlierberghe; Yves Horsmans; Dirk Sprengers; Ann Elewaut; Valeer Desmet; Geert Leroux-Roels; Emmanuel Quinaux; Erik Depla; Stephanie Dincq; Christine Vander Stichele; Geert Maertens; Frank Hulstaert
Journal:  Hepatology       Date:  2003-11       Impact factor: 17.425

5.  Hepatitis C virus genotype 1a growth and induction of autophagy.

Authors:  Malika Ait-Goughoulte; Tatsuo Kanda; Keith Meyer; Jan S Ryerse; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

6.  Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production.

Authors:  Kousuke Saito; Malika Ait-Goughoulte; Steven M Truscott; Keith Meyer; Azra Blazevic; Getahun Abate; Ratna B Ray; Daniel F Hoft; Ranjit Ray
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

7.  Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells.

Authors:  MinKyung Yi; Rodrigo A Villanueva; David L Thomas; Takaji Wakita; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

8.  Cytoskeleton rearrangement induced by tetraspanin engagement modulates the activation of T and NK cells.

Authors:  Stefania Crotta; Vanessa Ronconi; Cristina Ulivieri; Cosima T Baldari; Nicholas M Valiante; Nicholas M Valiente; Sergio Abrignani; Andreas Wack
Journal:  Eur J Immunol       Date:  2006-04       Impact factor: 5.532

9.  Spontaneous recovery in acute human hepatitis C virus infection: functional T-cell thresholds and relative importance of CD4 help.

Authors:  Susan Smyk-Pearson; Ian A Tester; Jared Klarquist; Brent E Palmer; Jean-Michel Pawlotsky; Lucy Golden-Mason; Hugo R Rosen
Journal:  J Virol       Date:  2007-11-28       Impact factor: 5.103

10.  Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses.

Authors:  Golo Ahlenstiel; Maureen P Martin; Xiaojiang Gao; Mary Carrington; Barbara Rehermann
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

View more
  10 in total

1.  Hepatitis C Virus Mediated Inhibition of miR-181c Activates ATM Signaling and Promotes Hepatocyte Growth.

Authors:  Tapas Patra; Keith Meyer; Ratna B Ray; Ranjit Ray
Journal:  Hepatology       Date:  2019-11-03       Impact factor: 17.425

Review 2.  The role of MDM2-p53 axis dysfunction in the hepatocellular carcinoma transformation.

Authors:  Hui Cao; Xiaosong Chen; Zhijun Wang; Lei Wang; Qiang Xia; Wei Zhang
Journal:  Cell Death Discov       Date:  2020-06-19

3.  Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations.

Authors:  Jannick Prentoe; Rodrigo Velázquez-Moctezuma; Elias H Augestad; Andrea Galli; Richard Wang; Mansun Law; Harvey Alter; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-30       Impact factor: 11.205

4.  Transforming Growth Factor β Acts as a Regulatory Molecule for Lipogenic Pathways among Hepatitis C Virus Genotype-Specific Infections.

Authors:  Tapas Patra; Reina Sasaki; Keith Meyer; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

5.  Retrospective Evaluation of Hepatitis C Awareness in Turkey Through Two Decades.

Authors:  Hatice Yasemin Balaban; Osman Dağ; Alparslan Alp; Nomingerel Tseveldorj; Cavanşir Vahabov; Mehmet Akif Göktaş; Tuğrul Pürnak; Gülşen Hasçelik; Hülya Demir; Bülent Sivri; Halis Şimşek
Journal:  Turk J Gastroenterol       Date:  2021-01       Impact factor: 1.852

Review 6.  The role of MDM2-p53 axis dysfunction in the hepatocellular carcinoma transformation.

Authors:  Hui Cao; Xiaosong Chen; Zhijun Wang; Lei Wang; Qiang Xia; Wei Zhang
Journal:  Cell Death Discov       Date:  2020-06-19

Review 7.  Strategies to Circumvent Host Innate Immune Response by Hepatitis C Virus.

Authors:  Tapas Patra; Ratna B Ray; Ranjit Ray
Journal:  Cells       Date:  2019-03-22       Impact factor: 6.600

Review 8.  Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis.

Authors:  Mousumi Khatun; Ratna B Ray
Journal:  Cells       Date:  2019-10-14       Impact factor: 6.600

9.  Improving the aqueous solubility of HCV-E2 glycoprotein epitope mimics by cyclization using POLAR hinges.

Authors:  Theodorus J Meuleman; Vanessa M Cowton; Arvind H Patel; Rob M J Liskamp
Journal:  J Pept Sci       Date:  2020-01       Impact factor: 1.905

10.  Hepatitis C Virus Evades Interferon Signaling by Suppressing Long Noncoding RNA Linc-Pint Involving C/EBP-β.

Authors:  Mousumi Khatun; Jinsong Zhang; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.